Clinical Outcomes With Ring Sideroblasts and SF3B1 Mutations in Myelodysplastic Syndromes: MDS Clinical Research Consortium Analysis
|
May 2018
|
Clin Lymphoma Myeloma Leuk
|
myelodysplastic syndromes (MDS)
|
Acquired Aplastic Anemia: What Have We Learned and What Is in the Horizon?
|
Jun 2018
|
Pediatr Clin North Am.
|
aplastic anemia
|
A systematic review of patient reported outcomes in phase II or III clinical trials of myelodysplastic syndromes and acute myeloid leukemia
|
Jun 2018
|
Leuk Res
|
myelodysplastic syndromes (MDS)
|
Iron overload in patients with myelodysplastic syndromes: An updated overview
|
Jun 2018
|
Cancer
|
myelodysplastic syndromes (MDS)
|
Transfusion-free interval is associated with improved survival in patients with higher-risk myelodysplastic syndromes engaged in routine care
|
Jun 2018
|
Leuk Lymphoma
|
myelodysplastic syndromes (MDS)
|
Diagnostic algorithm for lower-risk myelodysplastic syndromes
|
Jun 2018
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
Clinical consequences of iron overload in patients with myelodysplastic syndromes: the case for iron chelation therapy
|
Jul 2018
|
Expert Rev Hematol
|
myelodysplastic syndromes (MDS)
|
Paroxysmal nocturnal hemoglobinuria testing in patients with myelodysplastic syndrome in clinical practice-frequency and indications.
|
Oct 2018
|
Curr Oncol
|
myelodysplastic syndromes (MDS), paroxysmal nocturnal hemoglobinuria (PNH)
|
Complement-driven anemia: more than just paroxysmal nocturnal hemoglobinuria.
|
Nov 2018
|
Hematology Am Soc Hematol Educ Program
|
paroxysmal nocturnal hemoglobinuria (PNH)
|
Clinical Benefit-Risk Profile of Lenalidomide in Patients With Lower-risk Myelodysplastic Syndromes Without del(5q): Results of a Phase III Trial.
|
Dec 2018
|
Clin Lymphoma Myeloma Leuk
|
myelodysplastic syndromes (MDS)
|